Dementia Consortium Roadshow
Find out more about how the Dementia Consortium can support you
The Dementia Consortium is a global initiative launched in 2013 to accelerate early stage target validation and drug discovery. By providing researchers with funding, drug discovery expertise and project management, the Consortium aims to capitalise on emerging targets in neurodegeneration. Through industrial partners, we aim to move promising targets towards the clinic and share revenues with the originating scientists, with the ultimate goal of bringing benefit to people with dementia.
Earlier this year, the Dementia Consortium was renewed with new members Evotec and Johnson & Johnson joining, and up to £6 million made available for project funding over the next three years. Throughout the next year, we will be travelling around the UK to give you the opportunity to come and find out how the Dementia Consortium works, and how you could benefit from its collaborative funding.
Join us at the Edinburgh bioQuarter on Thursday 13 September to find out how the Dementia Consortium can support your research.
Date: Thursday 13 September 2018
Venue: Meeting room 1&2, Nine Edinburgh bioQuarter, 9 Little France Rd, Edinburgh EH16 4UX
Time: 3-5pm, followed by networking drinks and nibbles
|3:00-3:30pm||Dr Carol Routledge & Dr James Connell, Alzheimer’s Research UK – The Dementia Consortium: partnering academia with industry|
|3:30-3:45pm||Prof Tara Spires Jones, University of Edinburgh –
Crossing the Translational Valley of Death
|3:45-4:00pm||Dr Hugh Nuttall, Lilly|
||Dr Marco Baralle, International Centre for Genetic Engineering and Biotechnology|
|4:15-4:30pm||Evotec – Partners in drug discovery|
|5:15pm||Drinks and nibbles|